+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pigmentation Disorders Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4757209
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • ALLERGAN
  • Bayer AG
  • EpiPharm AG
  • Galderma laboratories
  • La Roche-Posay
  • Obagi Cosmeceuticals LLC.
  • MORE
The report on the global pigmentation disorders treatment market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global pigmentation disorders treatment market to grow with a CAGR of 5.9% over the forecast period from 2018-2024. The study on pigmentation disorders treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on pigmentation disorders treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pigmentation disorders treatment market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pigmentation disorders treatment market over the period of 2016 to 2024. Further, the author's growth matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Growing demand for several skin treatment products
  • Growing awareness about skin problem and availability of treatment remedy among consumers
2. Restraints
  • Costly treatment procedure of pigmentation disorder
3. Opportunities
  • Growth in medical tourism
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global pigmentation disorders treatment market is segmented on the basis of treatment & therapies, disease indication, and end-user.

The Global Pigmentation Disorders Treatment Market by Treatment & Therapies
  • Chemical Peels
  • Dermabrasion
  • Laser Resurfacing
  • Melasma
  • Others
The Global Pigmentation Disorders Treatment Market by Disease Indication
  • Hypopigmentation
  • Hyperpigmentation
The Global Pigmentation Disorders Treatment Market by End-user
  • Dermatology Clinics
  • Hospitals
  • Others
Company Profiles

The companies covered in the report include:
  • Bayer AG
  • Pierre Fabre Pharmaceuticals
  • EpiPharm AG
  • SkinCeuticals International
  • Galderma laboratories
  • VIVIERPHARMA
  • Obagi Cosmeceuticals LLC.
  • La Roche-Posay
  • ALLERGAN
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the pigmentation disorders treatment market.
2. Complete coverage of all the segments in the pigmentation disorders treatment market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global pigmentation disorders treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The growth matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ALLERGAN
  • Bayer AG
  • EpiPharm AG
  • Galderma laboratories
  • La Roche-Posay
  • Obagi Cosmeceuticals LLC.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Pigmentation Disorders Treatment Market Highlights
2.2. Pigmentation Disorders Treatment Market Projection
2.3. Pigmentation Disorders Treatment Market Regional Highlights

3. Global Pigmentation Disorders Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment & Therapies
3.4.2. Growth Matrix Analysis by Disease Indication
3.4.3. Growth Matrix Analysis by End-user
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Pigmentation Disorders Treatment Market

4. Pigmentation Disorders Treatment Market Macro Indicator Analysis

5. Global Pigmentation Disorders Treatment Market by Treatment & Therapies
5.1. Chemical Peels
5.2. Dermabrasion
5.3. Laser Resurfacing
5.4. Melasma
5.5. Others

6. Global Pigmentation Disorders Treatment Market by Disease Indication
6.1. Hypopigmentation
6.2. Hyperpigmentation

7. Global Pigmentation Disorders Treatment Market by End-user
7.1. Dermatology Clinics
7.2. Hospitals
7.3. Others

8. Global Pigmentation Disorders Treatment Market by Region 2018-2024
8.1. North America
8.1.1. North America Pigmentation Disorders Treatment Market by Treatment & Therapies
8.1.2. North America Pigmentation Disorders Treatment Market by Disease Indication
8.1.3. North America Pigmentation Disorders Treatment Market by End-user
8.1.4. North America Pigmentation Disorders Treatment Market by Country
8.2. Europe
8.2.1. Europe Pigmentation Disorders Treatment Market by Treatment & Therapies
8.2.2. Europe Pigmentation Disorders Treatment Market by Disease Indication
8.2.3. Europe Pigmentation Disorders Treatment Market by End-user
8.2.4. Europe Pigmentation Disorders Treatment Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Pigmentation Disorders Treatment Market by Treatment & Therapies
8.3.2. Asia-Pacific Pigmentation Disorders Treatment Market by Disease Indication
8.3.3. Asia-Pacific Pigmentation Disorders Treatment Market by End-user
8.3.4. Asia-Pacific Pigmentation Disorders Treatment Market by Country
8.4. RoW
8.4.1. RoW Pigmentation Disorders Treatment Market by Treatment & Therapies
8.4.2. RoW Pigmentation Disorders Treatment Market by Disease Indication
8.4.3. RoW Pigmentation Disorders Treatment Market by End-user
8.4.4. RoW Pigmentation Disorders Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Pigmentation Disorders Treatment Market
9.2. Companies Profiles
9.2.1. Bayer AG
9.2.2. Pierre Fabre Pharmaceuticals
9.2.3. EpiPharm AG
9.2.4. SkinCeuticals International
9.2.5. Galderma laboratories
9.2.6. VIVIERPHARMA
9.2.7. Obagi Cosmeceuticals LLC.
9.2.8. La Roche-Posay
9.2.9. ALLERGAN

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG
  • Pierre Fabre Pharmaceuticals
  • EpiPharm AG
  • SkinCeuticals International
  • Galderma laboratories
  • VIVIERPHARMA
  • Obagi Cosmeceuticals LLC.
  • La Roche-Posay
  • ALLERGAN
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4757209
Adroll
adroll